Home
OE Originals
OE Insights
CME
All Specialties
Arthroplasty
Cannabis
Ev. Based Medicine
Foot & Ankle
General Orthopaedics
Hand & Wrist
Metabolic Disorders
Osteoarthritis
Pediatric Orthopaedics
Peri-Operative
Phys. Therapy & Rehab
Shoulder & Elbow
Spine
Sports Medicine
Trauma
Tumour

Author Interviews

Conference Reports

PeerView

All Videos
(145 Videos)

Education
(9 Videos)
Innovation
(0 Videos)
Leadership
(3 Videos)
OrthoJoe
(21 Videos)
Other
(14 Videos)
Personal Growth
(1 Videos)
Practice
(2 Videos)
Research
(19 Videos)

COVID-19 Resource Center

OE World Tour

OE Perspectives

OE Ideas

OE Recommends

To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Loading...
Search Filters

Date Range

to

Report Types

ALL
RCT
META
ACE Reviews

Condition

Region of the Body

Specialties

See all (18)

Emerging Treatments

OE Recommends Topics

Multimedia

Journal

Conference Series

Evidence Series

We found 4 results matching your search query: "Risendronate"

Showing 1 - 4 of 4
Read Ace Report

AAOS: Quantitative ultrasound can detect the effects of risendronate on bone strength

RCT Trauma Postmenopausal Women Lower Extremity Hip Bone Femur Intertrochanteric Fracture Placebo Risendronate Ultrasound - Hide
Read Ace Report

Etidronate, alendronate, and reisendronate significantly reduce the risk of hip fracture

Curr Med Res Opin. 2011 Jun;27(6):1141-8. doi: 10.1185/03007995.2011.570747. Epub 2011 Apr 1

Meta-analysis General Orthopaedics Stroke Lower Extremity Hip Fracture Alendronate Alfacalcidol Control Oral Placebo Preventing Prevention Risendronate - Hide
Read Ace Report

Denosumab increases BMD and reduces bone turnover vs monthly oral bisphosphonate

Osteoporos Int. 2014 Jul;25(7):1953-61. doi: 10.1007/s00198-014-2692-7. Epub 2014 Mar 28.

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Fracture Amgen Risedronate Denosumab Bisphosphonate Ibandronate Oral - Hide
Read Ace Report

Zoledronic acid has no continued benefit beyond 6 years for osteoporosis

J Bone Miner Res. 2015 May;30(5):934-44.

RCT Osteoarthritis Osteoporosis Women Arthritis Fracture Novartis IV Infusion Placebo ZOL Zoledronic Acid - Hide
Showing 1 - 4 of 4